Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials

INTRODUCTION: Dalbavancin is a lipoglycopeptide antibiotic approved as a single- and two-dose regimen for adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive organisms. We present nephrotoxicity rates for patients with ABSSSI who received dalba...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Infect Dis Ther
Glavni autori: Gonzalez, Pedro L., Rappo, Urania, Mas Casullo, Veronica, Akinapelli, Karthik, McGregor, Jennifer S., Nelson, Jennifer, Nowak, Michael, Puttagunta, Sailaja, Dunne, Michael W.
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955009/
https://ncbi.nlm.nih.gov/pubmed/33515414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-021-00402-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items